A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice

NCT03532932 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1990

Last updated 2024-03-29

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to characterize the treatment patterns associated with biologics agents use or non-biological therapy in participants with moderate to severe Ulcerative Colitis (UC) and Crohn's Disease (CD).

Conditions

  • Colitis, Ulcerative
  • Crohn Disease
  • Inflammatory Bowel Diseases

Sponsors & Collaborators

Principal Investigators

  • Study Director · Takeda

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-20
Primary Completion
2021-11-08
Completion
2021-11-08

Countries

  • Belarus
  • Kazakhstan
  • Russia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03532932 on ClinicalTrials.gov